Tuberc Respir Dis.  1998 Oct;45(5):975-983.

Loss of Heterozygosity at 3p in Korean Non-Small Cell Lung Cancer

Affiliations
  • 1Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • 2Laboratory of Molecular Oncology, Korea Cancer Center Hospital, Seoul, Korea.
  • 3Department of Thoracic Surgery, Korea Cancer Center Hospital, Seoul, Korea.
  • 4Department of Microbiology, Changwon National University, Changwon, Korea.

Abstract

PURPOSE: Frequent deletion of 3p in numerous cancer including lung cancer suggests the presence of tumor suppressor gene. 3p has been analysed by RFLP and PCR-LOH of microsatellite locus. In this study, we observed the deletion of 3p in Korean NSCLC by PCR-LOH of 4 microsatellite loci and investigated the clinical significance. Method : 62 surgically rejected NSCLC DNA and normal lung DNA have been analysed by PCR-LOH at three dinucleotide[D3S1228 (3p14.1-14.3), D3S1067 (3p14.3-21.1), D3S1029 (3p21.1-21.3)] and one tetranucleotide[D3S1537 (Sp 22-24.2)] repeat microsatellite loci.
RESULTS
Among 59 informative cases, 3p deletion by PCR-LOH at four microsatellite loci was found in 31 patients (52.5%). 3p deletion were found in 55% of squamous cell lung cancer and 47% of adenocarcinoma patients. No significant difference has been found in clinical parameters such as staging, smoking and survival according to the status of 3p deletion.
CONCLUSION
Deletions in 3p have played an important role in Korean NSCLC though no clinical significance was detected.

Keyword

3p deletion; Non-small cell lung cancer(NSCLC); Microsatellite; PCR-LOH

MeSH Terms

Adenocarcinoma
Carcinoma, Non-Small-Cell Lung*
DNA
Genes, Tumor Suppressor
Humans
Loss of Heterozygosity*
Lung
Lung Neoplasms
Microsatellite Repeats
Polymorphism, Restriction Fragment Length
Smoke
Smoking
DNA
Smoke
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr